Drug Watch: Agents in late-stage development for the treatment of pulmonary diseases (March 2009) (PDF)

News
Article

Agents in late-stage development for the treatment of asthma, COPD, and PAH

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
coke plant battery | ©kefca stock.adobe.com

Study Shows Coke Plant Closure Near Pittsburgh Correlates with Decline in Respiratory Visits

Keith Loria
August 7th 2025
Article

Read More

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Briana Contreras
August 7th 2025
Podcast

Listen

piter2121-stock.adobe.com

Sarepta to Resume Shipping Elevidys For Ambulatory Duchenne Patients

Denise Myshko
August 7th 2025
Article

Read More

Creative mind-stock@adobe.com

PBM-Offered Genomics Testing Could Reshape Prescribing of Medications

Denise Myshko
August 7th 2025
Article

Read More

Anzupgo FDA Approved as First Treatment Meant for Chronic Hand Eczema in Adults

Anzupgo FDA Approved as First Treatment Meant for Chronic Hand Eczema in Adults

Briana Contreras
August 7th 2025
Article

Read More

nikitos77-stock@adobe.com

PBM Reform Could Save Almost $100 Billion in U.S. Drug Spending

Denise Myshko
August 7th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.